Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 24CNS 24Genitourinary 19Thoracic 17Sarcoma 15Head & Neck 9Other solid neoplasm 7Breast 7Tumor-Agnostic 3Lymphoid 3Endocrine 3Gynecologic 2Plasma cell 1Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 2Radiation Injuries 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Proton Therapy × Gynecologic × Clear all
NCT06462378 2024-06-17

Proton Therapy for Locally Advanced Cervical Cancer

University of Aarhus

Phase 2 Recruiting
55 enrolled
Gynecologic

Uterine Cervical Neoplasms, Radiation Injuries

NCT01019278 2020-04-03

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

Abramson Cancer Center at Penn Medicine

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡